Epigenetic Alterations Differ in Phenotypically Distinct Human Neuroblastoma Cell Lines

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2010 Jun 16

PMID 20546602

Citations 14

Authors

Qiwei Yang

Yufeng Tian

Kelly R Ostler

Alexandre Chlenski

Lisa J Guerrero

Helen R Salwen

Lucy A Godley

Susan L Cohn

Affiliations

Soon will be listed here.

Abstract

Background: Epigenetic aberrations and a CpG island methylator phenotype have been shown to be associated with poor outcomes in children with neuroblastoma (NB). Seven cancer related genes (THBS-1, CASP8, HIN-1, TIG-1, BLU, SPARC, and HIC-1) that have been shown to have epigenetic changes in adult cancers and play important roles in the regulation of angiogenesis, tumor growth, and apoptosis were analyzed to investigate the role epigenetic alterations play in determining NB phenotype.

Methods: Two NB cell lines (tumorigenic LA1-55n and non-tumorigenic LA1-5s) that differ in their ability to form colonies in soft agar and tumors in nude mice were used. Quantitative RNA expression analyses were performed on seven genes in LA1-5s, LA1-55n and 5-Aza-dC treated LA1-55n NB cell lines. The methylation status around THBS-1, HIN-1, TIG-1 and CASP8 promoters was examined using methylation specific PCR. Chromatin immunoprecipitation assay was used to examine histone modifications along the THBS-1 promoter. Luciferase assay was used to determine THBS-1 promoter activity. Cell proliferation assay was used to examine the effect of 5-Aza-dC on NB cell growth. The soft agar assay was used to determine the tumorigenicity.

Results: Promoter methylation values for THBS-1, HIN-1, TIG-1, and CASP8 were higher in LA1-55n cells compared to LA1-5s cells. Consistent with the promoter methylation status, lower levels of gene expression were detected in the LA1-55n cells. Histone marks associated with repressive chromatin states (H3K9Me3, H3K27Me3, and H3K4Me3) were identified in the THBS-1 promoter region in the LA1-55n cells, but not the LA1-5s cells. In contrast, the three histone codes associated with an active chromatin state (acetyl H3, acetyl H4, and H3K4Me3) were present in the THBS-1 promoter region in LA1-5s cells, but not the LA1-55n cells, suggesting that an accessible chromatin structure is important for THBS-1 expression. We also show that 5-Aza-dC treatment of LA1-55n cells alters the DNA methylation status and the histone code in the THBS-1 promoter modifies cell morphology, and inhibits their ability to form colonies in soft agar.

Conclusion: Our results suggest that epigenetic aberrations contribute to NB phenotype, and that tumorigenic properties can be inhibited by reversing the epigenetic changes with 5-Aza-dC.

Citing Articles

Prediction of Composite Clinical Outcomes for Childhood Neuroblastoma Using Multi-Omics Data and Machine Learning.

Wang P, Zhang J Int J Mol Sci. 2025; 26(1.

PMID: 39795994 PMC: 11720239. DOI: 10.3390/ijms26010136.

The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma.

Yang Q, Bariani M, Falahati A, Khosh A, Lastra R, Siblini H Cells. 2022; 11(14).

PMID: 35883603 PMC: 9323884. DOI: 10.3390/cells11142160.

5-aza-2'-Deoxycytidine Induces a RIG-I-Related Innate Immune Response by Modulating Mitochondria Stress in Neuroblastoma.

Lin H, Chuang J, Wang P, Lin T, Wu M, Hsu W Cells. 2020; 9(9).

PMID: 32824929 PMC: 7564572. DOI: 10.3390/cells9091920.

Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids.

Yang Q, Laknaur A, Elam L, Ismail N, Gavrilova-Jordan L, Lue J Reprod Sci. 2016; 23(10):1314-25.

PMID: 27036951 PMC: 5933176. DOI: 10.1177/1933719116638186.

The Polycomb Group Protein EZH2 Impairs DNA Damage Repair Gene Expression in Human Uterine Fibroids.

Yang Q, Nair S, Laknaur A, Ismail N, Diamond M, Al-Hendy A Biol Reprod. 2016; 94(3):69.

PMID: 26888970 PMC: 4829092. DOI: 10.1095/biolreprod.115.134924.

References

Wales M, Biel M, El Deiry W, Nelkin B, Issa J, Cavenee W . p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med. 1995; 1(6):570-7. DOI: 10.1038/nm0695-570. View

Yang Q, Kiernan C, Tian Y, Salwen H, Chlenski A, Brumback B . Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome. Clin Cancer Res. 2007; 13(11):3191-7. DOI: 10.1158/1078-0432.CCR-06-2846. View

Schmidt M, Salwen H, Manohar C, Ikegaki N, Cohn S . The biological effects of antisense N-myc expression in human neuroblastoma. Cell Growth Differ. 1994; 5(2):171-8. View

Krop I, Sgroi D, Porter D, Lunetta K, LeVangie R, Seth P . HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Proc Natl Acad Sci U S A. 2001; 98(17):9796-801. PMC: 55532. DOI: 10.1073/pnas.171138398. View

Reynolds C, Tomayko M, DONNER L, Helson L, Seeger R, Triche T . Biological classification of cell lines derived from human extra-cranial neural tumors. Prog Clin Biol Res. 1988; 271:291-306. View

Suzuki M, Hao C, Takahashi T, Shigematsu H, Shivapurkar N, Sathyanarayana U . Aberrant methylation of SPARC in human lung cancers. Br J Cancer. 2005; 92(5):942-8. PMC: 2361924. DOI: 10.1038/sj.bjc.6602376. View

Yang Q, Liu S, Tian Y, Salwen H, Chlenski A, Weinstein J . Methylation-associated silencing of the thrombospondin-1 gene in human neuroblastoma. Cancer Res. 2003; 63(19):6299-310. View

Foley J, Cohn S, Salwen H, Chagnovich D, Cowan J, Mason K . Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line. Cancer Res. 1991; 51(23 Pt 1):6338-45. View

Abe M, Ohira M, Kaneda A, Yagi Y, Yamamoto S, Kitano Y . CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas. Cancer Res. 2005; 65(3):828-34. View

10.

Zhang J, Liu L, Pfeifer G . Methylation of the retinoid response gene TIG1 in prostate cancer correlates with methylation of the retinoic acid receptor beta gene. Oncogene. 2003; 23(12):2241-9. DOI: 10.1038/sj.onc.1207328. View

11.

Yang Q, Tian Y, Liu S, Zeine R, Chlenski A, Salwen H . Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma. Cancer Res. 2007; 67(4):1716-24. DOI: 10.1158/0008-5472.CAN-06-2595. View

12.

Liu X, Chen H, Zhang X, Pan Z, Li A, Feng Q . Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma. Int J Cancer. 2003; 106(1):60-5. DOI: 10.1002/ijc.11166. View

13.

Issa J . CpG island methylator phenotype in cancer. Nat Rev Cancer. 2004; 4(12):988-93. DOI: 10.1038/nrc1507. View

14.

Teitz T, Wei T, Valentine M, Vanin E, Grenet J, Valentine V . Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med. 2000; 6(5):529-35. DOI: 10.1038/75007. View

15.

Abe M, Watanabe N, McDonell N, Takato T, Ohira M, Nakagawara A . Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis. Oncology. 2008; 74(1-2):50-60. DOI: 10.1159/000139124. View

16.

Yang Q, Zage P, Kagan D, Tian Y, Seshadri R, Salwen H . Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma. Clin Cancer Res. 2004; 10(24):8493-500. DOI: 10.1158/1078-0432.CCR-04-1331. View

17.

Hesson L, Cooper W, Latif F . Evaluation of the 3p21.3 tumour-suppressor gene cluster. Oncogene. 2007; 26(52):7283-301. DOI: 10.1038/sj.onc.1210547. View

18.

Abe M, Westermann F, Nakagawara A, Takato T, Schwab M, Ushijima T . Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas. Cancer Lett. 2006; 247(2):253-8. DOI: 10.1016/j.canlet.2006.05.001. View

19.

Chlenski A, Liu S, Crawford S, Volpert O, DeVries G, Evangelista A . SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. Cancer Res. 2002; 62(24):7357-63. View

20.

Maris J, Hogarty M, Bagatell R, Cohn S . Neuroblastoma. Lancet. 2007; 369(9579):2106-20. DOI: 10.1016/S0140-6736(07)60983-0. View